Overview
Board of Directors
Scientific Advisory Board
Senior Management
Drug Discovery Partnerships
Clients & Collaborators
Business Strategy
Clients & Collaborators
PsychoGenics has established Research Agreements with over 100 clients and collaborators including:
7TM Pharma
ErgoNex Pharma
Psychiatric Genomics
Addex Pharmaceuticals
Harvard / Massachusetts General
Purdue Pharma.
Adolor
Helicon Therapeutics
Radius Health Inc.
AGY Therapeutics
High Q Foundation
Regenion GmbH.
ALS Association
Howard Associates, LCC
Roche
Astra Zeneca
Intra-cellular Therapies.
Ruxton Pharmaceuticals
Aestus Therapeutics.
Janssen Pharmaceutica
Rexahn Pharmaceuticals.
Araim Pharmaceuticals.
Kadmus Pharmaceuticals
Saegis Pharmaceuticals
ARYx Therapeutics.
Luitpold Pharmaceuticals.
Salk Institute
Bristol-Myers Squibb Company
MindGenix
Schering-Plough Research Institute
Bionomics.
Mindset BioPharmaceuticals Ltd.
Sepracor
Biovitrum.
Mixture Sciences
Serono
BrainCells Inc.
Medivation.
Spinal Muscular Atrophy Foundation
CuraGen
Neuralstem Inc.
Sangamo Biosciences.
Cara Therapeutics Inc.
Neurome, Inc.
Shire.
Cambria.
Neuromolecular
Servier
Cypress Bioscience.
NIH/NINDS
Tapestry Pharmaceuticals
CytRx Corporation.
NPS Pharmaceuticals
Tularik Inc.
deCode Genetics
NeuroNascent.
UCB Pharma.
DOV Pharmaceutical.
Orion Pharma
XenoPort, Inc.
Dainippon Sumitomo Pharma.
Ore Pharmaceuticals.
Eli Lilly and Company
Predix Pharmaceuticals